Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer
Daniel Nava Rodrigues(Royal Marsden NHS Foundation Trust), Charles G. Drake(Johns Hopkins Medicine), George Seed(Institute of Cancer Research), Larissa Mendes(Royal Marsden Hospital), Pasquale Rescigno(Royal Marsden NHS Foundation Trust), Michael T. Schweizer(Fred Hutch Cancer Center), Gunther Boysen, Joshua Armenia(Memorial Sloan Kettering Cancer Center), Mary‐Ellen Taplin(University of Massachusetts Chan Medical School), Stephen J. Salipante(University of Washington), Diana Miao(Broad Institute), David Dolling(Institute of Cancer Research), Nikolaus Schultz(Memorial Sloan Kettering Cancer Center), Charles L. Sawyers(Memorial Sloan Kettering Cancer Center), Mark A. Rubin(University of Bern), Joaquı́n Mateo(Hebron University), Mateus Crespo(Institute of Cancer Research), Alan D. D’Andrea(Dana-Farber Cancer Institute), Himisha Beltran(Cornell University), Marcin Cieślik(University of Michigan), Kelly P. Burke(Harvard University), Claire A. Margolis(Broad Institute), Wassim Abida(Memorial Sloan Kettering Cancer Center), Susana Miranda(Royal Marsden NHS Foundation Trust), Colin C. Pritchard(University of Washington), Matthew Clarke, Peter S. Nelson(University of Washington), Adam Sharp(Institute of Cancer Research), Howard I. Scher(Kantonsspital Baselland Standort Bruderholz), Kent W. Mouw(Broad Institute), Ana Ferreira(Institute of Cancer Research), Dan R. Robinson(University of Michigan), Zafeiris Zafeiriou(Royal Marsden NHS Foundation Trust), Daniel Keliher(Broad Institute), Andrea Alimonti(Veneto Institute of Molecular Medicine), Suzanne Carreira(Institute of Cancer Research), Christopher J. Lord(Institute of Cancer Research), Diletta Bianchini(Royal Marsden NHS Foundation Trust), Saud H. AlDubayan(Broad Institute), David Liu(Broad Institute), Ruth Riisnaes(Institute of Cancer Research), Ines Figueiredo(Institute of Cancer Research), Stephanie A. Mullane(Broad Institute), Mariane Fontes(Royal Marsden NHS Foundation Trust), Arul M. Chinnaiyan(Howard Hughes Medical Institute), Elizabeth Heath, Cláudia Bertan(Institute of Cancer Research), Maryou Lambros(Institute of Cancer Research), Semini Sumanasuriya(Institute of Cancer Research)
Cited by 53
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k